Skip to main content

Table 1 Expression of lnc-SNHG1 in serous epithelial ovarian cancer tissues

From: Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer

  lnc-SNHG1   
  Total cases High expression (n = 37) Low expression (n = 58) χ2 P
Age (year) n n % n % 0.074 0.786
Postmenopausal (< 50) 42 17 40.48 25 59.52   
Premenopausal (50) 53 20 37.74 33 62.26   
Tumor stage (FIGO)       8.435 0.015
I-II 21 4 19.05 17 80.95   
III 45 16 35.56 29 64.44   
IV 29 17 58.62 12 41.38   
Histological grade (n = 88)       6.529 0.011
H 72 34 47.22 38 52.78   
L 16 2 12.50 14 87.50   
Nodal status (n)       13.323 0.0001
Negative 60 15 25.00 45 75.00   
Positive 35 22 62.86 13 37.14   
Tumor diameter (cm)       0.343 0.842
< 10 cm 30 12 40.00 18 60.00   
10–20 cm 58 23 39.66 35 60.34   
> 20 cm 7 2 28.57 5 71.43   
Chemotherapy       31.148 0.0001
Chemoresistance 32 25 78.13 7 21.87   
Chemosensitivity 63 12 19.05 51 80.95   
Metastasis       25.499 0.0001
Y 19 17 89.47 2 10.53   
N 76 20 26.32 56 73.68